Loblaw Companies Limited · TSX:L
Loblaw Companies — Q4 2016 Earnings Presentation
6 slides from Loblaw Companies's earnings presentation, Feb 23, 2017
Slide 1: Q4 2016 Supplementary Slides
Q4 2016 Supplementary Slides February 23, 2017 1
Slide 2: Forward-looking Statements
Forward-looking Statements This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opport unit
Slide 3: Key Financial Metrics – Loblaw – Q4 2016
Key Financial Metrics – Loblaw – Q4 2016 Consolidated Revenue $ 11,130M +2.4% Adjusted EBITDAand Margin $ 956M +8.5% +8.6% +50bps Adjusted Diluted Earnings Per Common +11.5% $ 0.97 Share Free Cash Flow QTD $ 313M QTD (2015 $36M) Capex ($) QTD $ 470M QTD (2015 $433M) Free Cash Flow YTD $ 1,821M YTD (
Slide 4: Key Retail Metrics – Q4 2016
Key Retail Metrics – Q4 2016 Total Retail Revenue $ 10,845M +2.3% Retail Revenue - Food Retail $ 7,789M +2.1% Retail Revenue - Drug Retail $ 3,056M +2.7% $ 2,838M 26.4% -20bps Retail Adjusted Gross Profit & Margin (Excluding the impact of the consolidation of franchises) (As Reported: $2,945 million
Slide 5: Key Operational Metrics – Q4 2016 – Loblaw
Key Operational Metrics–Q4 2016—Loblaw +1.1% (Includes a 1.0% favourable impact of an extra selling day , due to Food Retail Same-Store Sales Growth the timing of New Years day) Basket Size Traffic Internal Inflation Loblaw inflation declined and is slightly lower than CPI of -2.3% Loblaw STM Square
Slide 6: Key Operational Metrics – Shoppers Drug Mart
Key Operational Metrics – Q4 2016 Shoppers Drug Mart Pharmacy Sales $ 1,361M +3.5% Pharmacy SSS +2.5% (2015 +4.2%) # Rx Dispensed (Rx Count) +5.0% (2015 % -4.7%) +4.5% (2015 3.2%) Average Rx Value -2.0% (2015 +0.9%) Front of Store Sales $ 1,695M +2.1% Front of Store SSS +4.1% (2015 +5.7%) 6